Skip to main content
Premium Trial:

Request an Annual Quote

HGS Names Two to Board, Initiates Trials


ROCKVILLE, Md.--Human Genome Sciences here has made two appointments to its board of directors. Jurgen Drews, recently retired president for global research for the Roche Group of Hoffmann-LaRoche has joined the board and will serve on its executive committee. Alan Spoon, president and chief operating officer of the Washington Post, was also named to the board.

Meanwhile, board member Joshua Ruch has resigned for personal reasons, the company reported. He had served on the board, which has 12 members, since the company's founding.

In other developments, the company has begun enrolling patients in two separate Phase I studies of its keratinocyte growth factor-2 (KGF-2), a new human protein that is being evaluated as a wound-healing treatment. The product, which was discovered by Human Genome scientists, is significant as the second genomics-derived therapeutic candidate to enter human clinical testing.

The trials are double-blind, placebo-controlled studies to evaluate the safety and efficacy of KGF-2 and gain information for additional studies. "KGF-2 is one of the many new proteins that Human Genome Sciences' scientists have discovered and are developing based on our powerful approach to genomic and functional genomic analysis," commented William Haseltine, the company's chairman and CEO.

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.